You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-IL13 antibody [32116.11] (ab10782)

Overview

  • Product nameAnti-IL13 antibody [32116.11]See all IL13 primary antibodies ...
  • Description
    Mouse monoclonal [32116.11] to IL13
  • Tested applicationsWB, Neutralising, ELISA more details
  • Species reactivity
    Reacts with: Human
  • Immunogen

    Recombinant full length human IL13 protein expressed in E. coli.

  • Positive controlab10782 has the ability to neutralize the bioactivity of human IL13 in the human erythroleukemia cell line, TF-1.

Properties

  • FormLiquid
  • Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
  • Storage bufferConstituents: PBS
  • Concentration information loading...
  • PurityProtein A purified
  • Purification notesThe antibody is purified from the IgG fraction of ascities fluid using Protein A chromotography.
  • Clonality Monoclonal
  • Clone number32116.11
  • IsotypeIgG1
  • Research Areas

Applications

Our Abpromise guarantee covers the use of ab10782 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Notes
WB
Neutralising
ELISA
  • Application notesELISA: Use at a concentration of 4 µg/ml (100 ul/well) in combination with a biotinylated IL13 polyclonal detection antibody at 400 ng/ml (100 µl/well), an ELISA for sample volumes of 100 µl with a range of 62.5-4000 ug/ml can be obtained.
    Neut: Use at a concentration of 1-3 µg/ml in the presence of 10 ng/ml of recombinant human IL13 using the human erythroleukemia cell line, TF-1.
    WB: Use at a concentration of 1-2 µg/ml. Detects a band of approximately 9 kDa (predicted molecular weight: 12 kDa). The detection limit for recombinant human IL13 is approximately 50 ng/lane under non-reducing and reducing conditions.

    Endotoxin level is < 10 ng/mg antibody as determined by the LAL (Limulus amebocyte lysate) method.

    Not tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • Target

    • FunctionCytokine. Inhibits inflammatory cytokine production. Synergizes with IL2 in regulating interferon-gamma synthesis. May be critical in regulating inflammatory and immune responses.
    • Involvement in diseaseDefects in IL13 may be a cause of susceptibility to allergic rhinitis (ALRH) [MIM:607154]. Allergic rhinitis is a common disease of complex inheritance and is characterized by mucosal inflammation caused by allergen exposure.
    • Sequence similaritiesBelongs to the IL-4/IL-13 family.
    • Cellular localizationSecreted.
    • Target information above from: UniProt accession P35225 The UniProt Consortium
      The Universal Protein Resource (UniProt) in 2010
      Nucleic Acids Res. 38:D142-D148 (2010) .

      Information by UniProt
    • Database links
    • Alternative names
        Allergic rhinitis antibodyALRH antibodyBHR 1 antibody
        BHR1 antibodyBronchial hyperresponsiveness 1 (bronchial asthma) antibodyIL 13 antibodyIL-13 antibodyIL13 antibodyIL13_HUMAN antibodyInterleukin 13 antibodyInterleukin-13 antibodyInterleukin13 antibodyMGC116786 antibodyMGC116788 antibodyMGC116789 antibodyNC30 antibodyP600 antibody
      see all

    References for Anti-IL13 antibody [32116.11] (ab10782)

    ab10782 has not yet been referenced specifically in any publications.

    Product Wall

    Displaying 1 - 1 of 1 results for Abreviews and Q&A

    Thank you for your enquiry. Unfortunately the affinity constant for this antibody has not been determined. If you have any additional questions, please contact us again.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"